What sector does Aarey Drugs & Pharm Ltd belong to?

Aarey Drugs & Pharm Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of AAREYDRUGS?

As of the latest available quote, AAREYDRUGS traded at ₹98.89. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of AAREYDRUGS?

Aarey Drugs & Pharm Ltd has a price-to-earnings (P/E) ratio of about 76.66. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of AAREYDRUGS?

The market capitalisation of Aarey Drugs & Pharm Ltd is approximately ₹305 Cr.

Is Aarey Drugs & Pharm Ltd profitable?

For its latest reported financial year, Aarey Drugs & Pharm Ltd recorded a net profit margin of about 0.85%.

Does AAREYDRUGS pay a dividend?

Aarey Drugs & Pharm Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of AAREYDRUGS?

Aarey Drugs & Pharm Ltd has a return on equity (ROE) of about 2.75%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of AAREYDRUGS?

Over the past 52 weeks, AAREYDRUGS has traded between a low of ₹50.31 and a high of ₹101.29.

Aarey Drugs & Pharm Ltd

AAREYDRUGS NSE Healthcare Pharmaceuticals

₹98.89

+3.32%

Delayed · cached 15 min

Fair value analysis

AAREYDRUGS

Aarey Drugs & Pharm Ltd

₹95.71

Close used for this calculation

₹33.77Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

22/100

Profitability11/25

Returns0/25

Balance Sheet9/25

Efficiency2/25

Growth3/25

Weak

Quality radar

Consensus fair value

₹33.77

Above FV

▼ -64.7% against the close used

Model range ₹10.08 – ₹49.98

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹10.08Fair value₹33.77Bull₹49.98

FairClose

52-week traded range

52W low ₹50.7552W high ₹99.98

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Aarey Drugs & Pharm Ltd closed at ₹95.71, 183.4% above the consensus fair value of ₹33.77 drawn from 9 valuation models.

Financial DNA score 22/100 — Weak. P/E of 73.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹25.06

-73.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=7.2%, r=10%, tg=3%, n=10yr

Graham Number

₹39.52

-58.7%

√(22.5 × EPS × BVPS)

EPS=1.4, BVPS=49.59 · outside Graham range (P/E 73.2, P/B 1.9) — asset-light, treat as a rough floor

Graham Formula

₹29.77

-68.9%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=7.2%, FD=7%

P/E Fair Value

₹49.98

-47.8%

EPS × 35.7x (sector P/E)

EPS=1.4, Sector P/E=35.7x

Peter Lynch (PEG)

₹10.08

-89.5%

EPS × Growth% (PEG = 1 is fair)

EPS=1.4, g=7.2%

EV/EBITDA

₹26.99

-71.8%

(EBITDA × 13.6x − Net Debt) ÷ Shares

EBITDA=100M

Book Value (P/B)

₹13.64

-85.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=49.59, ROE=2.8%, g=6%, r=10%

Reverse DCF

₹95.71

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 23.8% | Historical: 7.2%

Margin of Safety

₹27.06

-71.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=36.08, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer